Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 2/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | RPS6KA2 | Q15349 | 1/20 | 0.32 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 3/20 | 0.31 |
| ▸ | CA1 | P00915 | 3/20 | 0.31 |
| ▸ | CA2 | P00918 | 3/20 | 0.31 |
| ▸ | CA3 | P07451 | 3/20 | 0.31 |
| ▸ | CA4 | P22748 | 3/20 | 0.31 |
| ▸ | CA6 | P23280 | 3/20 | 0.31 |
| ▸ | CA5A | P35218 | 3/20 | 0.31 |
| ▸ | CA7 | P43166 | 3/20 | 0.31 |
| ▸ | CA9 | Q16790 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL498441 | 0.99 | MAPT (0.35) | MAPTHSD17B10IDO1ALDH1A1TP53 | |
| SCHEMBL11298623 | 0.89 | CDK2 (0.37) | MAPTHSD17B10IDO1ALDH1A1TP53 | |
| SCHEMBL1347821 | 0.82 | S100B (0.38) | MAPTHSD17B10ALDH1A1TP53HTT | |
| SCHEMBL7209657 | 0.82 | MAPT (0.35) | MAPTHSD17B10ALDH1A1TP53HTT | |
| SCHEMBL17847418 | 0.79 | ALDH1A1 (0.33) | MAPTHSD17B10ALDH1A1TP53HTT | |
| SCHEMBL20497202 | 0.79 | CYP1A2 (0.37) | MAPTHSD17B10ALDH1A1TP53HTT | |
| SCHEMBL5050234 | 0.77 | IDO1 (0.33) | MAPTHSD17B10IDO1ALDH1A1TP53 | |
| SCHEMBL29822211 | 0.77 | IDO1 (0.33) | MAPTHSD17B10IDO1ALDH1A1TP53 | |
| SCHEMBL29565964 | 0.77 | IDO1 (0.33) | MAPTHSD17B10IDO1ALDH1A1TP53 | |
| SCHEMBL29912733 | 0.77 | IDO1 (0.33) | MAPTHSD17B10IDO1ALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7346387-B1 | Methods for improved selectivity in photo-activation and detection of molecular diagnostic agents | PROVECTUS DEVICETECH, INC. (US) | 2008-03-18 | — | — | US | disclosed |
| US-20080015189-A1 | Antimicrobial photoinactivation using chalcogen analogs of benzo(A)phenoxazinium dyes | THE GENERAL HOSPITAL CORPORATION (US) | 2008-01-17 | — | — | US | disclosed |
| EP-1467760-A2 | SYSTEMS AND METHODS FOR PHOTODYNAMIC THERAPY | Light Sciences Corporation (US) | 2004-10-20 | — | — | EP | disclosed |
| US-20030167033-A1 | Systems and methods for photodynamic therapy | LIGHT SCIENCES CORPORATION | 2003-09-04 | — | — | US | disclosed |
| WO-2003061696-A2 | SYSTEMS AND METHODS FOR PHOTODYNAMIC THERAPY | LIGHT SCIENCES CORPORATION (US) | 2003-07-31 | — | — | WO | disclosed |
| EP-0977592-A4 | METHOD FOR IMPROVED SELECTIVITY IN PHOTO-ACTIVATION OF MOLECULAR AGENTS | PHOTOGEN INC (US) | 2001-01-10 | — | — | EP | disclosed |
| EP-1032321-A4 | METHOD FOR IMPROVED SELECTIVITY IN PHOTO-ACTIVATION AND DETECTION OF MOLECULAR DIAGNOSTIC AGENTS | PHOTOGEN INC (US) | 2000-09-06 | — | — | EP | disclosed |
| EP-1032321-A1 | METHOD FOR IMPROVED SELECTIVITY IN PHOTO-ACTIVATION AND DETECTION OF MOLECULAR DIAGNOSTIC AGENTS | Photogen, Inc. (US) | 2000-09-06 | — | — | EP | disclosed |
| US-6042603-A | Method for improved selectivity in photo-activation of molecular agents | PHOTOGEN, INC. (US) | 2000-03-28 | — | — | US | disclosed |
| EP-0977592-A1 | METHOD FOR IMPROVED SELECTIVITY IN PHOTO-ACTIVATION OF MOLECULAR AGENTS | Photogen, Inc. (US) | 2000-02-09 | — | — | EP | disclosed |
| US-5998597-A | THE TREATMENT OF A PARTICULAR VOLUME OF PLANT OR ANIMAL TISSUE COMPRISING THE STEPS OF TREATING THE PLANT OR ANIMAL TISSUE WITH AT LEAST ONE PHOTO-ACTIVE MOLECULAR AGENT. | PHOTOGEN, INC. (US) | 1999-12-07 | — | — | US | disclosed |
| WO-1998018398-A1 | METHOD FOR IMPROVED SELECTIVITY IN PHOTO-ACTIVATION AND DETECTION OF MOLECULAR DIAGNOSTIC AGENTS | PHOTOGEN, INC. (US) | 1998-05-07 | — | — | WO | disclosed |
| WO-1998018399-A1 | METHOD FOR IMPROVED SELECTIVITY IN PHOTO-ACTIVATION OF MOLECULAR AGENTS | PHOTOGEN, INC. (US) | 1998-05-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080015189-A1 | Antimicrobial photoinactivation using chalcogen analogs of benzo(A)phenoxazinium dyes | BLVRB, CUTA, TYR | MAPT 3310/4885HSD17B10 646/4885IDO1 995/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.